Ensysce Biosciences to participate in upcoming conference events
Ensysce Biosciences said it will take part in upcoming conference and industry event participation.
SAN DIEGO, CA / / September 2, 2026 / Ensysce Biosciences, Inc.
NASDAQ:ENSC ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today an…